Which Vagus Nerve Stimulation Side Effects Are Expected? Hoarseness, Cough and When to Call

Key Takeaways
- Hoarseness, cough and throat tingling with VNS occur during the seconds the device is stimulating and stop between bursts, which is what distinguishes them from a complication.
- The stimulator is placed on the left vagus nerve because the right side carries most of the fibres that control heart rate, keeping cardiac effects during long-term therapy rare.
- Published trial reviews show stimulation-related side effects peak during the first months of setting adjustment and decline through the first and second years of therapy.
- Constant hoarseness that persists even when the device is paused with the magnet can indicate vocal cord weakness from surgery and needs assessment rather than reprogramming.
- VNS can worsen obstructive sleep apnea by briefly narrowing the airway, so screening before implantation and reporting new snoring afterward are both standard advice.
- Seizure reduction from VNS builds gradually over one to two years, so benefit is usually judged at the one-year mark, well after the early side effects have appeared.
The most common vagus nerve stimulation side effects are hoarseness or a changed voice, a tickling cough, throat discomfort, and mild shortness of breath, which usually happen only while the device is delivering a pulse and tend to ease over the first months. Surgery-related risks such as infection or vocal cord weakness are less common. New chest pain, fainting, fever, or wound redness warrant a prompt call to the care team.
Two weeks after her stimulator was switched on, a woman I spoke with noticed that her sentences had developed a rhythm she had not chosen. Every few minutes, mid-word, her voice dipped into a soft rasp, held there for half a minute, and then returned as if nothing had happened. Her husband called it her radio fading in and out. She called her nurse.
That call is one of the most frequent ones epilepsy and psychiatry teams receive in the weeks after a vagus nerve stimulator is activated, and the answer is usually reassuring. Yet the vns side effects people worry about in advance, and the ones that actually deserve a phone call, are not the same list.
This explainer separates the two. It walks through what the device does to the nerve, why the voice and throat bear the brunt of it, what tends to fade and what tends to stay, and the handful of signs that should never be waited out.
What is vagus nerve stimulation and how does it actually work?
The vagus nerve is the longest cranial nerve, a two-sided cable that runs from the brainstem down the neck and into the chest and abdomen, carrying signals to and from the heart, lungs, larynx and gut. Vagus nerve stimulation, usually shortened to VNS, means delivering small, timed electrical pulses to that nerve so the signals travel upward into the brain.
In the implanted form, a surgeon places a pulse generator about the size of a large coin under the skin of the upper chest, then threads a thin wire up to the left vagus nerve in the neck and wraps a small electrode around it. The left side is chosen because the right vagus carries more of the fibres that set heart rhythm, according to Mayo Clinic.
Once activated, the generator cycles on and off around the clock. A stimulation burst lasts seconds, followed by a longer rest, and this pattern repeats many times an hour without the person needing to do anything. Programming happens from outside the body with a handheld wand; no further surgery is needed to adjust it.
Why does stimulating a nerve in the neck alter what happens in the brain? Roughly 80 percent of vagal fibres carry information upward, toward the nucleus of the solitary tract in the brainstem and onward to regions involved in arousal, mood and seizure threshold. Reviews summarized on the NIH Bookshelf describe changes in neurotransmitter release, including norepinephrine and serotonin, and shifts in cortical excitability, though the exact chain of events that reduces seizures is still being mapped.
A non-invasive version also exists. Handheld or ear-clip devices press electrodes against the skin over a vagal branch, in the neck or the outer ear, without any surgery. These are used mainly for certain headache disorders and carry a different, generally milder, side-effect profile that this article covers separately.
Which VNS side effects are expected in the first weeks?
Almost everything on the expected list has one thing in common: it happens during the seconds the device is actively stimulating, and it stops when the pulse stops. Because the electrode sits in the neck, right beside the branch of the vagus that controls the vocal cords and the throat, the nearby structures feel the current.

Mayo Clinic and Cleveland Clinic both list the same core group. A hoarse or altered voice tops it. A dry, tickling cough follows, along with throat pain or a scratchy sensation, mild shortness of breath, a prickling or tingling feeling in the skin of the neck, headache, and occasional difficulty swallowing. Some people notice their voice pitch changes rather than dropping into a rasp.
These are stimulation-dependent, which matters for two reasons. First, they are a sign the electrode is in contact with the nerve and the system is functioning. Second, they are adjustable. The programming clinician can lower the current, change the pulse width or shorten the burst, and most of the throat effects soften accordingly. That is why teams typically raise the settings in small steps over several visits rather than all at once.
A separate, quieter group of early effects relates to the operation itself rather than the stimulation: soreness at the chest and neck incisions, some swelling, tightness when turning the head, and fatigue in the first week or two. Those belong to any minor surgery and follow a wound-healing timeline.
What is not expected in the first weeks is anything that feels cardiac, any fever with wound changes, or a voice that stays hoarse continuously rather than in bursts. Those patterns point to something other than ordinary stimulation and are covered in the red-flag section later.
Why does vagus nerve stimulation cause hoarseness, and does it fade?
Hoarseness is the signature side effect of VNS for a mechanical reason. The recurrent laryngeal nerve, which moves the vocal cords, branches off the vagus in the neck and chest. Some of its fibres run inside the trunk the electrode encircles. When the pulse fires, those motor fibres fire too, and the left vocal cord tightens or shifts. The result is the rasping, breathy or lower-pitched voice people describe, lasting exactly as long as the burst.
Reviews summarized on the NIH Bookshelf report voice alteration as the most frequently recorded side effect in the pivotal epilepsy trials, affecting a majority of participants at higher stimulation settings and a smaller share at lower ones. Mayo Clinic lists it first among common effects for the same reason. Vagus nerve stimulation hoarseness is, in other words, less a complication than a predictable feature of where the wire sits.
Whether it fades depends on what is causing it. Stimulation-related hoarseness tends to become less noticeable over months. The same reviews describe rates falling substantially by the first and second year of therapy, partly because the nervous system accommodates and partly because clinicians settle on a tolerable setting. Many long-term users say they stop registering it unless someone points it out.
Hoarseness that is constant, present even when the device is switched off with the magnet, or accompanied by a weak cough or choking on liquids is a different matter. That pattern can indicate injury to the recurrent laryngeal nerve during surgery, producing a vocal cord that does not move. It is uncommon, and Cleveland Clinic notes it is usually temporary, but it should be assessed by the surgical team rather than assumed to be ordinary stimulation.
Singers, teachers and people who speak professionally sometimes ask whether they should avoid VNS. There is no rule; it is a conversation about priorities, and worth having explicitly before surgery.
Cough, throat tickle and shortness of breath: what is happening
The cough that arrives with a stimulation burst is usually dry and reflexive, more of a throat-clearing tickle than a chesty cough. It comes from the same neighbourhood as the hoarseness: sensory fibres in the vagus supply the lining of the larynx and upper airway, and when they are stimulated the brain interprets the signal as something to be cleared.

Shortness of breath during stimulation has two contributors. One is the brief narrowing of the airway when the left vocal cord tightens. The other is subtler: the vagus carries signals to the muscles of breathing and to the airways themselves, and some people feel a momentary catch in their rhythm. Mayo Clinic lists both cough and shortness of breath as common effects; both are typically mild and stimulation-linked.
Exercise can amplify them. Reviews on the NIH Bookshelf note that dyspnea during exertion may be more noticeable because breathing is already working harder when the pulse arrives. People who run or cycle often learn to time a rest at the moment the burst begins, or their clinician adjusts the on-time so that the interruption is shorter.
Difficulty swallowing is less common but follows the same logic, since vagal fibres coordinate the pharynx. If it happens, the practical advice from clinical teams is to swallow between bursts and to avoid large mouthfuls while the device is on. It is worth telling the programming clinician about any swallowing change, because a modest reduction in current often resolves it.
Two features distinguish expected breathing effects from concerning ones. Expected effects are rhythmic and predictable, matching the device cycle, and they resolve within the burst. Breathlessness that persists between bursts, appears at rest for the first time, or comes with chest tightness or a racing heart does not fit that pattern and needs medical attention the same day.
VNS side effects at a glance: common, less common and rare
Sorting vns side effects by how often they occur and whether they are tied to stimulation or to surgery makes the whole picture easier to hold in mind. The categories below follow the groupings used by Mayo Clinic, Cleveland Clinic and the NIH Bookshelf review; frequencies are described in words because published rates vary with the settings used and how long people were followed.
| Effect | How often | Linked to | Typical course |
|---|---|---|---|
| Hoarseness or voice change | Common; the most frequently reported | Stimulation | Occurs during bursts; tends to lessen over months |
| Cough or throat tickle | Common | Stimulation | Brief, during bursts; adjustable |
| Throat pain or tingling in neck | Common | Stimulation | Often eases with accommodation or lower settings |
| Shortness of breath | Common, milder | Stimulation | More noticeable with exertion |
| Headache, difficulty swallowing, sleep disturbance | Less common | Stimulation | Usually responds to reprogramming |
| Incision pain, swelling, bruising | Common early | Surgery | Resolves with wound healing over weeks |
| Wound infection | Uncommon | Surgery | Needs assessment; may require treatment or device removal |
| Vocal cord weakness or paralysis | Uncommon | Surgery | Often temporary; assessed by the surgical team |
| Lead movement or fracture | Uncommon | Device | May need revision surgery |
| Slow heart rate during lead testing | Rare | Surgery | Occurs in the operating room, monitored |
| Worsening of sleep apnea | Uncommon | Stimulation | Screened for before and after implantation |
The table carries one honest caveat. Most published side-effect data come from epilepsy trials, where people were followed for years. Data for depression and stroke rehabilitation are thinner, and the non-invasive devices have their own, largely skin-related, profile. The pattern of stimulation-linked throat effects being common and surgical complications being uncommon holds across all of them.
Vagus nerve stimulator risks from the surgery itself
Implanting a stimulator is a short operation, often done under general anesthesia and frequently as a day procedure or single overnight stay, according to Cleveland Clinic. Even short operations carry risks, and separating these from the stimulation effects helps people know what to watch for and when.
Infection at either incision is the surgical complication that most often leads to further intervention. Cleveland Clinic and the NIH Bookshelf review both describe it as uncommon but meaningful, because an infection that reaches the generator pocket or tracks along the lead is hard to clear with antibiotics alone and sometimes requires removing the hardware. Redness that spreads, warmth, pus, wound edges pulling apart or a fever in the first weeks are the signs teams ask people to report the same day.
Vocal cord paralysis is the second notable surgical risk. Handling the vagus during electrode placement can bruise or stretch the fibres that move the left vocal cord, leaving it fixed. The voice becomes continuously weak or breathy, rather than intermittently hoarse, and swallowing thin liquids may cause coughing. Cleveland Clinic notes this is usually temporary as the nerve recovers, though a small number of cases persist.
Lead problems round out the list. The wire can shift, fracture with years of neck movement, or lose contact with the nerve. The usual clue is that stimulation sensations disappear, or seizure control changes. Diagnosis involves checking the device’s impedance readings and imaging, and treatment may mean a revision operation.
Rare intraoperative events include a temporary slowing of the heart when the surgeon first tests the lead, which is why heart rhythm is monitored during placement. Bleeding, nerve injury to nearby structures and reactions to anesthesia are the generic risks of any neck surgery. Vagus nerve stimulator risks of this kind are discussed in the consent conversation, and asking the surgeon how they are monitored is entirely reasonable.
Can VNS affect the heart or breathing during sleep?
The vagus nerve is the body’s main brake on heart rate, so the question of cardiac effects is a fair one. The reassuring part comes from anatomy and design. The stimulator is placed on the left vagus specifically because the right side carries the majority of fibres to the sinoatrial node, the heart’s natural pacemaker, and reviews on the NIH Bookshelf describe clinically significant heart-rhythm effects during long-term therapy as rare.
The moment of highest cardiac attention is in the operating room. When the surgeon first tests the electrode, a brief slowing of the heart or a short pause has been reported in a very small proportion of cases. It is transient, resolves when the stimulation is stopped, and is one reason continuous monitoring is standard during placement. Once the device is programmed and running, this pattern does not typically recur.
People with pre-existing heart rhythm disorders, or those who have fainted from vagal reflexes, should raise this before surgery so the team can decide on any additional cardiac evaluation. Palpitations, dizziness or fainting after activation are not expected effects and warrant a same-day call.
Breathing during sleep is a more established concern. Because stimulation can briefly narrow the upper airway, VNS may worsen obstructive sleep apnea, a condition in which the throat repeatedly closes during sleep. Mayo Clinic lists worsening sleep apnea among possible effects, and clinical teams often ask about snoring, daytime sleepiness and witnessed pauses in breathing before implantation, sometimes arranging a sleep study.
If apnea worsens, options include adjusting the stimulation settings or using positive airway pressure therapy at night. Some programmable devices can be set to reduce stimulation during typical sleeping hours. A new or louder snore after activation is worth mentioning at the next visit rather than dismissing.
Who is VNS usually for, and who is usually asked to wait?
Implanted VNS is not a first-line treatment for anything. It sits behind medication and, where relevant, behind an assessment for surgery that could remove the source of seizures. The NHS describes it as an option for epilepsy when seizures are not controlled with medicine and resective brain surgery is not suitable or has not helped.
Within epilepsy, the typical candidate is an adult or child, generally from around age four, with focal seizures that have persisted despite adequate trials of at least two appropriate medicines. Mayo Clinic notes it can also be considered in some generalized epilepsies. The goal is fewer and less severe seizures, not their complete elimination, and that expectation is set early.
The second established use is treatment-resistant depression in adults, meaning depression that has not responded to several trials of medication and psychotherapy. Here it is used alongside, not instead of, ongoing treatment. A newer use pairs stimulation with rehabilitation exercises to support arm recovery after ischemic stroke, and the non-invasive devices are used for cluster headache and migraine.
Who is usually asked to wait or look elsewhere? People who have not yet had a full epilepsy surgery evaluation, because removing a seizure focus can offer more than stimulation ever will. Those with an active infection, since implanting hardware into infected tissue is unwise. People with significant untreated sleep apnea or certain heart rhythm problems may need those addressed first. Prior surgery or radiation to the left neck can make the anatomy unsuitable, and anyone who cannot tolerate a general anesthetic needs that risk weighed.
None of this is a verdict a reader can pass on themselves. Candidacy depends on seizure type, imaging, prior treatments and personal priorities, and the treating team weighs all of them together.
Do vagus nerve stimulation devices work? What the evidence shows
The honest answer is that implanted VNS works modestly and gradually for the conditions it is approved for, and that its effect grows over time rather than appearing at once.
For drug-resistant epilepsy, the NIH Bookshelf review of the randomized trials and long-term registries describes a reduction in seizure frequency that increases over the first one to two years of therapy, with a substantial minority of people eventually experiencing at least a halving of their seizures. Mayo Clinic frames the same evidence plainly: most people do not become seizure-free, and the benefit is a reduction in number and severity, often alongside shorter recovery after seizures and, for some, an improvement in mood and alertness that is independent of seizure control.
That slow build is worth stressing because it shapes how side effects are judged. Someone experiencing hoarseness in month two without yet seeing fewer seizures may reasonably ask whether it is worth it. Clinical teams generally advise assessing benefit at the one-year mark and beyond, not in the early weeks.
For treatment-resistant depression, the evidence is thinner and more debated. Long-term observational studies suggest a proportion of people improve over one to two years, but randomized data are limited and the trials that exist showed smaller short-term differences than hoped. Reviews describe it as a reasonable option after many others have failed, not as a reliably effective one.
Paired VNS for stroke rehabilitation has one randomized controlled trial showing improved arm function compared with rehabilitation plus sham stimulation, which is promising but limited to a single study population. For headache, the non-invasive devices have trial support for acute cluster headache and some support in migraine, with more mixed results for prevention.
What the evidence does not support are the claims made for consumer gadgets marketed for stress, weight or general wellness. Those have not been tested to the same standard.
Is there a best FDA-approved vagus nerve stimulation device?
People searching for the best approved device are asking a sensible question with an unsatisfying answer: no comparative trial has shown one system to be superior to another, and the choice is rarely the patient’s main decision.
For implanted therapy, the regulated systems share the same essential architecture, a pulse generator, a lead and a cuff electrode, and are approved for the same core indications. Where they differ is in generation. Newer models add features such as detecting a rapid rise in heart rate, which often precedes seizures, and delivering an extra burst automatically; longer battery life; and the option to schedule lower stimulation at night. Whether those features matter depends on the person’s seizure pattern, and an epilepsy team chooses the model with that in mind.
Non-invasive devices are a separate category. They are approved for specific headache disorders, are used on demand rather than continuously, and cannot be compared with implanted systems because they treat different problems.
What about the consumer market? Devices sold online for stress, sleep or focus that claim to stimulate the vagus nerve through the ear or neck are, in most cases, not evaluated by regulators as medical treatments and have not been tested in the kind of trials that support the implanted and headache devices. The absence of surgical risk does not make them effective; it makes them low-risk and unproven.
The more useful question to ask a care team is not which brand is best but which features, if any, address your specific situation, how the device will be programmed and by whom, what happens when the battery needs replacing, and how the team handles MRI requests. Those answers will vary far more between clinics than between manufacturers.
What the days and weeks after implantation usually look like
The timeline divides neatly into two phases: healing from the operation, then adjusting to the stimulation. They overlap less than people expect, because most teams leave the device off, or at a very low setting, for the first couple of weeks.
In the first few days, the two incisions in the chest and neck are sore and possibly bruised. Turning the head fully is uncomfortable. Cleveland Clinic describes most people going home the same day or after one night, with advice to keep the wounds clean and dry, avoid heavy lifting and avoid vigorous neck movements until the surgeon has checked the sites. Fatigue for a week or so is common after any general anesthetic.
Around two weeks, the wounds are reviewed and, if healing well, the device is typically activated at a low level. This is when stimulation-related effects first appear, and they are usually mild at these settings. Some people feel almost nothing; others notice the voice flicker immediately.
Over the following one to three months, settings are increased gradually at a series of visits, often every few weeks. Each step tends to bring a temporary uptick in hoarseness or cough that settles before the next adjustment. Reviews on the NIH Bookshelf describe this titration period as the window of highest side-effect intensity, with rates declining from the first year onward as accommodation occurs and a stable setting is reached.
Benefit, as covered above, arrives later than the side effects. Seizure diaries are usually reviewed at three, six and twelve months, and many teams reserve judgement on effectiveness until the one-year mark or beyond.
Driving restrictions after seizures are governed by local law and by seizure control, not by the device; the team will advise. Returning to work depends on the job, and most people are back within one to two weeks once wounds are comfortable.
Living with a VNS device: magnets, MRI, batteries and daily life
Once settled, a stimulator asks little day to day, but it comes with a small set of rules that are easy to keep once understood.
The magnet is the first. People are given a small magnet to wear or carry. Swiped across the generator, it triggers an extra burst of stimulation, which some use at the first sign of a seizure. Held over the generator, it pauses stimulation for as long as it stays there, which is useful for a job interview, a solo in choir or a moment when hoarseness is unwelcome. Removing it restarts the cycle. Mayo Clinic describes both functions as standard.
MRI scanning is the second. Older systems were incompatible with MRI; newer ones permit scans under specific conditions, often requiring the device to be programmed to a safe mode beforehand and certain body regions or scanner types to be avoided. Anyone with a stimulator should carry the device card and tell every radiology department about it before any scan. Ordinary X-rays, CT scans and dental X-rays are not a problem.
Other electrical or magnetic equipment is a lesser concern. Household appliances, phones and airport security are generally fine, though people are advised to walk through security scanners rather than lingering, and to keep strong magnets, including some headphones and tablet covers, away from the chest, since they can unintentionally pause the device.
The battery is finite. Depending on the settings, generators last several years before the whole unit needs replacing in a short operation that leaves the lead in place. Regular check-ups track the battery, and a change in stimulation sensations can signal that it is running low.
Contact sports and activities with heavy chest impact are usually discussed individually. Swimming, running and most gym work are unrestricted once wounds have healed.
What people often get wrong about VNS side effects
Several widely shared beliefs about vns side effects are simply not supported, and a few point people in unhelpful directions.
The first is that hoarseness means something has gone wrong. In almost every case it means the opposite: the electrode is where it should be and the current is reaching the nerve. It is constant hoarseness, present with the device paused, that deserves concern, not intermittent hoarseness that follows the cycle.
The second is that side effects will get worse over time. The published pattern runs the other way. Rates of voice change, cough and throat discomfort are highest during the first months of adjustment and decline through the first and second years, according to the NIH Bookshelf review, as the nervous system accommodates and settings stabilize. Vns therapy long term effects that do emerge, such as lead wear or battery depletion, are mechanical rather than a worsening of the throat symptoms.
The third concerns the phrase an overactive vagus nerve. It circulates widely online as an explanation for fatigue, gut problems, dizziness or anxiety. In clinical medicine, excessive vagal activity refers to something specific: the vasovagal reflex that can slow the heart and lower blood pressure, causing fainting in response to pain, standing or emotional triggers. It is not a general syndrome, and a stimulator does not create it.
The fourth is the idea that people can calm down their vagus nerve with a purchased gadget or a protocol. Slow, paced breathing does measurably increase vagal tone, which is part of why it helps some people feel calmer, and simple manoeuvres such as bearing down are used clinically to interrupt certain fast heart rhythms. Those are real. The marketed resets, oils and ear clips promising to fix stress or inflammation have not been tested to a standard that supports the claims, and buying them because of a hoarse voice after implantation addresses nothing.
Finally, VNS is sometimes described as a last resort. It is better understood as one option among several for hard-to-treat conditions, chosen when its particular trade-offs fit the person.
Non-invasive VNS side effects: how they differ
Transcutaneous stimulators, which press electrodes against the skin of the neck or the outer ear, have become the entry point for many people curious about the therapy, so their side-effect profile deserves a section of its own. The short version is that non invasive vns side effects are mostly about the skin and the moment of use, not about surgery or continuous stimulation.
Because nothing is implanted, there is no wound, no infection risk at a generator pocket and no lead to fracture. The current still reaches vagal fibres, so some of the familiar sensations appear during a session: a tingling or pulling at the skin under the electrode, a brief change in voice, a tickle in the throat, and occasionally mild dizziness or a headache afterward. Trials of the neck device for cluster headache, summarized in the NIH Bookshelf review, reported these as generally mild and short-lived.
Skin irritation is the effect most specific to this route. Conductive gel, repeated pressure and the current itself can redden the skin, and people with sensitive skin or eczema sometimes find the sites sore with frequent use. Rotating position slightly and cleaning the skin help; persistent irritation should be mentioned to the prescribing clinician.
The ear-clip devices stimulate the auricular branch of the vagus, a small sensory twig in the outer ear. Reported effects include local discomfort, ear redness and, rarely, dizziness or nausea during use. Because the auricular branch carries no motor fibres to the larynx, hoarseness is not expected with these.
Two cautions apply. First, these devices are approved for specific headache indications, and using them for other conditions is off-label and largely untested. Second, they are not risk-free for everyone: people with implanted cardiac devices, carotid artery disease or a history of fainting from vagal reflexes are usually advised to discuss use with a clinician first, since stimulating the neck can affect heart rate and blood pressure.
Questions to ask your care team
The most valuable conversations about a stimulator happen before the incision and again in the months after activation. These questions draw on what patients most often say they wish they had asked.
Before surgery, it helps to establish where VNS sits in the wider plan. Have I had a full evaluation for other surgical options, and why is stimulation being suggested over them? What realistic change in seizures, mood or function are you hoping to see, and when would you expect to judge it? What are the reasons I might not be a good candidate, and have they been ruled out? Have I been screened for sleep apnea and heart rhythm problems?
On the operation itself: how often does your team see wound infection or vocal cord weakness, and how do you monitor heart rhythm during lead testing? Will I go home the same day? How will my medicines be managed around the anesthetic, and who decides that?
On the weeks after: when will the device be switched on, and how quickly will settings be increased? Who programs it, and how do I reach them if hoarseness or cough becomes hard to live with? Which effects should I simply report at the next visit, and which mean I should call the same day?
On daily life: is my particular device MRI-conditional, and what steps are needed before a scan? How long is the battery expected to last at my settings? Are there activities I should avoid? How do I use the magnet, and should family members learn too?
On the long view: if it does not help, what does removal involve, and does the lead stay? How will we decide together whether to continue? Writing the answers down, or bringing someone to listen, turns a rushed consultation into a record you can return to.
When to call your doctor
Most stimulation effects can wait for the next scheduled visit, where a small change in settings usually sorts them out. A short list should not wait.
Call the same day, or seek urgent care, if any of the following appear: fever with spreading redness, warmth, swelling, discharge or opening at either incision; chest pain, palpitations, a noticeably slow or irregular pulse, dizziness or fainting; shortness of breath that persists between stimulation bursts or appears for the first time at rest; a voice that is continuously weak or hoarse rather than intermittently, especially with choking on liquids or a cough that has lost its force; new or severe pain, numbness or weakness in the neck, shoulder or arm on the side of the device; a sudden disappearance of all stimulation sensations alongside a rise in seizures, which can signal a lead or battery problem; or any seizure that is longer, more severe or different in kind from the usual pattern.
Emergency services are appropriate for a seizure lasting more than five minutes, repeated seizures without recovery in between, difficulty breathing that does not ease, or collapse.
Mention at the next routine visit, or sooner if troubling: hoarseness or cough that is louder than you can live with; new snoring or daytime sleepiness suggesting sleep apnea; swallowing that feels effortful; headaches that began with activation; mood changes; or skin irritation from a non-invasive device that does not settle.
Keep the device identification card with you, and tell any clinician treating you for anything else, including dentists and radiographers, that you have a stimulator. If in doubt about whether a symptom is expected, the programming team would far rather take a call than hear about it weeks later. Every adjustment, pause or removal decision rests with them, made together with you.
Frequently asked questions
What are the most common vagus nerve stimulation side effects?
Hoarseness or a changed voice, a tickling cough, throat pain or tingling, and mild shortness of breath are the most frequently reported effects, according to Mayo Clinic and Cleveland Clinic. They happen while the device is delivering a pulse and stop when it rests. Headache, difficulty swallowing and sleep disturbance are less common. Most soften with setting adjustments and with time.
Does vagus nerve stimulation hoarseness go away?
For most people it lessens considerably over months. Trial reviews describe voice change as the most common early effect, with rates falling during the first and second year as the nervous system accommodates and clinicians settle on a tolerable setting. Hoarseness that is constant, rather than tied to the stimulation cycle, is different and should be assessed by the surgical team.
Do vagus nerve stimulation devices work?
For drug-resistant epilepsy, evidence shows a gradual reduction in seizure frequency that increases over one to two years, though few people become seizure-free. Evidence for treatment-resistant depression is thinner and debated. Paired VNS for stroke rehabilitation and non-invasive devices for certain headaches have supporting trials. Consumer wellness gadgets have not been tested to the same standard.
Which FDA-approved vagus nerve stimulation device is considered the best?
No head-to-head trial shows one system to be superior. Approved implanted devices share the same basic design and indications, differing mainly in features such as heart-rate-triggered bursts, battery life and scheduling options. Non-invasive devices treat different conditions and cannot be compared directly. The more useful question for a care team is which features suit your seizure pattern.
What are the symptoms of an overactive vagus nerve?
In clinical terms, excessive vagal activity refers to the vasovagal reflex: a sudden slowing of the heart and drop in blood pressure that causes light-headedness, sweating, nausea and fainting in response to triggers such as pain or standing. The broader online idea of a general overactive vagus syndrome causing fatigue or anxiety is not an established diagnosis, and VNS does not create one.
How can I calm down my vagus nerve without a device?
Slow, paced breathing measurably increases vagal tone and is a reasonable, low-risk way to feel calmer. Certain physical manoeuvres, such as bearing down, are used clinically to interrupt specific fast heart rhythms and should only be done on medical advice. Marketed vagus nerve resets, ear clips and supplements have not been shown in trials to treat stress, inflammation or any medical condition.
What are the main vagus nerve stimulator risks from surgery?
The notable surgical risks are wound infection, which is uncommon but can require device removal if it reaches the generator or lead; temporary or, rarely, lasting vocal cord weakness from handling the nerve; lead movement or fracture over time; and a rare brief slowing of the heart during lead testing in the operating room, which is why heart rhythm is monitored throughout.
What are the long term effects of VNS therapy?
Long-term follow-up in epilepsy registries shows stimulation-related throat effects diminishing over years rather than accumulating. The issues that emerge later are mechanical: battery depletion requiring generator replacement, lead wear and occasional need for revision surgery. Worsening sleep apnea can develop and is screened for. No progressive nerve damage from ongoing stimulation has been established in these follow-up studies.
Are non-invasive VNS side effects different from implanted VNS?
Yes. With no surgery there is no wound infection or lead risk. Effects are mostly skin irritation, tingling under the electrode, brief voice change or throat tickle during use, and occasionally dizziness or headache. Ear-clip devices do not typically cause hoarseness. People with implanted cardiac devices, carotid disease or a fainting history are advised to discuss use with a clinician first.
Can I have an MRI with a vagus nerve stimulator?
It depends on the model. Older systems were not compatible; newer ones allow scanning under specific conditions, often requiring the device to be set to a safe mode beforehand and limits on scanner type or body region. Always show the device card and tell radiology staff before any scan. X-rays, CT scans and dental imaging are not affected.
References
- Cleveland Clinic — Vagus Nerve Stimulation (VNS)
- NHS — Epilepsy: Treatment
- NIH National Library of Medicine (StatPearls) — Vagus Nerve Stimulation
- MedlinePlus — Epilepsy
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
More from the Blog
Multiple Sclerosis Treatment: How Relapse Control and Disease-Modifying Therapy Fit Together
Multiple sclerosis is treated on three fronts at once. Short courses of corticosteroids shorten a relapse, and plasma exchange is reserved for severe relapses…
What Does a Sleep Study for Narcolepsy Involve? The Overnight Test and Daytime Nap Test
A sleep study for narcolepsy usually combines two tests over roughly 24 hours: an overnight polysomnogram that records brain waves, breathing, heart rate and…
Mild Cognitive Impairment vs Dementia: How the Care Plans Differ
Mild cognitive impairment (MCI) means measurable thinking changes that do not yet stop a person managing daily life independently; dementia means those changes have…



